Navigation Links
PCMA: CMS Releases Proposed E-Prescribing Standards in Medicare
Date:11/14/2007

E-Prescribing Will Improve Savings, Reduce Medication Errors

WASHINGTON, Nov. 14 /PRNewswire-USNewswire/-- The Pharmaceutical Care Management Association (PCMA) said today that the proposed standards for electronic prescribing (e-prescribing) released by the Centers for Medicare & Medicaid Services (CMS) confirm that the time is now to require e-prescribing in Medicare.

Following four years of extensive review by physicians, pharmacists, standard-setting organizations, and other stakeholders, CMS estimates tremendous savings and health benefits with increased adoption of e-prescribing. In the proposed standards, CMS estimates found that adoption of e-prescribing would:

-- Reduce Adverse Drug Events (ADEs);

-- Provide increased administrative savings to physicians, physician offices and pharmacists; and

-- Enhance generic utilization.

"CMS estimates even modest adoption of e-prescribing could save billions and greatly reduce adverse drug events (ADEs)," said PCMA President and CEO Mark Merritt.

The proposed e-prescribing standards were developed and pilot-tested during a rigorous process with consensus from a variety of influential health care stakeholders, including physicians; pharmacists; payers; the Department of Health and Human Services (HHS); the National Committee on Vital Health Statistics; and HIPAA-recognized standard setting organizations. In a positive note regarding interoperability, the proposed e-prescribing standards were created by the same organizations which developed Electronic Medical Records (EMR) standards. Requiring e-prescribing in Medicare is the first step toward broader adoption of overall health IT and would also serve as a model for the entire commercial market.

In the 2003 Medicare Modernization Act (MMA), Part D sponsors were required to accept e-prescribing and national standards were created for Medicare, however, physicians were not required to use the technology. As a result, fewer than one-in-ten physicians have chosen to use it. PCMA strongly believes the only realistic way to rapidly accelerate adoption of e-prescribing is to require physicians to use the technology in Medicare.

E-prescribing helps consumers avoid medication errors by providing physicians with real-time safety alerts when a new prescription would dangerously interact with others that have already been prescribed. Earlier this year, PCMA released a study from the Gorman Health Group showing that requiring e-prescribing in Medicare could prevent up to 1.9 million medication errors over the next decade and save billions -- even after providing funds for equipment and training.

PCMA last week launched a TV and print advertising campaign featuring J. Lyle Bootman, Ph.D., Sc.D., who last year co-chaired an Institute of Medicine (IOM) committee that recommended that all physicians begin using e-prescribing by 2010. In the TV ad, Dr. Bootman calls on policymakers to require e-prescribing in Medicare, "before more people die."

The new PCMA TV ad is available at http://www.pcmanet.org.

PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
2. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
3. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
4. Verdict One Releases Directory of Board Certified Attorneys for Consumers
5. Academy releases emergency preparedness tools to enable millions more people to shelter in place
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. MITEM Releases Blue Iris eLaborate 8.6
8. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
9. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
10. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
11. Cardiac Science Releases New Cardiac Rehabilitation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... , ... May 26, 2017 , ... ... of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface ... browser-based interface for diagnostic device operations. With this platform, initializing devices and importing ...
(Date:5/26/2017)... ... May 26, 2017 , ... Boar’s Head ... bold recipes for Memorial Day entertaining that are sure to satisfy your guests’ ... fresh sliced meats and cheeses featured in these refreshingly balanced recipes are packed ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... On May ... (AHCA), which narrowly passed the U.S. House on May 4, would result in 23 ... expected under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... week that is focusing on the Peace Agreements being discussed by President Donald Trump ... in a race to try to speed up peace talks in the continuous battle ...
(Date:5/26/2017)... ... ... Rob Lowe acts as host and helps educate and inform the public using the ... can reconnect with America as it explores some of the best places to hike ... an inventive new place for a family vacation, and have discovered hiking. Many will ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... , May 17, 2017  Bayer announced today that ... will be presented at the 53 rd Annual ... taking place June 2-6 in Chicago ... ASCO span prostate, colorectal, liver and thyroid cancers, as ... the Phase II CHRONOS-1 trial of copanlisib in patients ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: